Business Context and Reporting Period
This Form 8-K reports the consummation of the Initial Public Offering (IPO) and related transactions for Eureka Acquisition Corp, a Cayman Islands-based special purpose acquisition company. The reporting period covers events from July 1, 2024, through July 8, 2024, including the effectiveness of the Registration Statement, the closing of the IPO, the exercise of the over-allotment option, and the appointment of new directors.
Key Financial Metrics
- Public Offering Proceeds: The Company sold 5,000,000 Units at $10.00 per Unit, generating $50,000,000 in gross proceeds. Subsequently, the underwriters exercised the over-allotment option in full, selling an additional 750,000 Units at $10.00 per Unit, generating $7,500,000 in gross proceeds. Total Public Units sold: 5,750,000.
- Private Placement Proceeds: The Company sold 216,750 Initial Private Units and 11,250 Additional Private Units to the Sponsor (Hercules Capital Management Corp) at $10.00 per unit, generating total gross proceeds of $2,280,000.
- Total Gross Proceeds: $59,780,000 (combining Public and Private sales).
- Trust Account Funding: A total of $57,500,000 was placed in the trust account, net of transaction expenses and working capital.
- Underwriting Compensation: The Company issued 230,000 Representative Shares initially and an additional 30,000 Representative Shares upon the exercise of the over-allotment option (total 260,000 shares).
- Debt and Liquidity: The filing does not provide specific details on outstanding debt or current liquidity ratios outside of the trust account balance.
Material Changes
As this filing marks the Company's IPO, there is no prior comparable period for financial performance. The material change is the transition from a private entity to a public company listed on The Nasdaq Stock Market LLC under the symbols EURKU (Units), EURK (Class A ordinary shares), and EURKR (Rights). The Company has established a trust account holding $57,500,000 to fund a potential initial business combination.
Outlook, Risks, and Management Commentary
- Business Combination Deadline: The Company must complete its initial business combination by July 3, 2025. This deadline may be extended up to July 3, 2026, or January 3, 2026, depending on specific conditions and shareholder votes.
- Redemption Rights: Public shareholders have the right to redeem their shares for a pro rata portion of the trust account if the Company fails to complete a business combination by the deadline or in connection with certain amendments to the charter.
- Corporate Governance: Effective July 1, 2024, Dr. M. Anthony Wong, Ms. Lauren Simmons, and Mr. Kevin McKenzie were appointed as independent directors. Dr. Wong serves as the chair of the audit committee and is designated as an audit committee financial expert.
- Risks: The primary risk is the failure to complete an initial business combination within the specified timeframe, which would trigger a liquidation and distribution of trust funds to shareholders.
Investor Verification Checklist
- Verify the exact amount of funds remaining in the trust account after deducting any transaction expenses not yet accounted for in the $57,500,000 figure.
- Review the Underwriting Agreement (Exhibit 1.1) for details on lock-up periods and the specific conditions for the over-allotment option.
- Confirm the terms of the Sponsor's Private Units, specifically regarding their redemption rights and liquidation preferences compared to public shares.
- Examine the Second Amended and Restated Memorandum and Articles of Association (Exhibit 3.1) for the precise mechanics of the extension deadlines and redemption triggers.
- Monitor the Company's progress in identifying a target business combination prior to the July 3, 2025 deadline.